Avenue Therapeutics Inc

NASDAQ:ATXI   11:09:05 AM EDT
6.61
-0.65 (-8.95%)
Equity Financing / Related

Avenue Therapeutics Provides Regulatory Update For IV Tramadol

Published: 09/22/2022 20:32 GMT
Avenue Therapeutics Inc (ATXI) - Avenue Therapeutics Announces Reverse Stock Split and Provides Regulatory Update for Iv Tramadol Including Receipt of Type a Meeting Minutes From the FDA.
Avenue Therapeutics Inc - Today Announced That It Will Effect a 1-for-15 Reverse Split of Its Common Stock.
Avenue Therapeutics Inc- Reverse Split of Common Stock, Will Be Effective for Trading Purposes on Nasdaq, on Sept 23, 2022.
Avenue Therapeutics Inc - Received Official Meeting Minutes From FDA Regarding a Meeting Conducted on August 9, 2022, for Iv Tramadol.